Report #2825782

Received Feb 11, 2025

Hospitalized

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 4 yrs
State: MA
Recovered: Recovered
Vaccinated: Sep 29, 2023
Onset: Dec 21, 2024
Days to onset: 449
Hospital days: 11

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MMRV	MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)	MERCK & CO. INC.	2	NDC 0006-4171-0	IM / UN
VARCEL	VARICELLA (VARIVAX)	MERCK & CO. INC.	1	NDC 0006-4827-0	IM / UN

Symptoms (7)

CSF test abnormalHeadacheOphthalmic herpes zosterRashRash vesicularVaricella virus test positiveVomiting

Symptom narrative

Presumably healthy patient. He received first vaccine against VZV at ~2 yrs on 12/21/2021 (Varivax - NDC 0006-4827-00) and second vaccine at ~4 yrs on 9/29/2023 (Proquad - NDC 0006-4171-01). At age 5 yrs, he presented to Hospital w/ right-sided herpes zoster ophthalmicus. Pt had a ~8-day prodrome of frontal HA and occasional emesis before developing a vesicular rash over his right CNV1 dermatome, which was present for ~2 days before admission. Pt had normal mental status on presentation. However, given his HA and emesis, LP was done w/ reassuring CSF indices, but VZV PCR was positive. CSF was sent to lab for wild-type vs. vaccine strain VZV PCR, and it resulted + for vaccine strain, prompting this submission. We will also do an immune work-up.

Current illness

None

Medical history

None

Other medications

None

Allergies

None known

Lab data

Please see above